Company intelligence / Profile preview

BW Apothecary Holdings

United States

Ownership: Private
Development stage: Other

Overview

BW Apothecary Holdings LLC was the parent entity for the 340B Link business (and possibly related service assets), providing software and solutions to help entities manage participation in the federal 340B Drug Pricing Program. The 340B Link business generated approximately $35 million in revenue (unaudited) for the 12 months ended June 30, 2020.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on BW Apothecary Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BW Apothecary Holdings.

Explore the full profile